Skip to main content
Fig. 2 | Surgical and Experimental Pathology

Fig. 2

From: Clinical, pathological and prognostic implications of USP22, SIRT1 and E-cadherin expression in papillary thyroid cancer (PTC) and adjacent non-neoplastic tissue

Fig. 2

Immunohistochemical expression of SIRT1 in in papillary thyroid carcinoma (PTC) a High expression in the nucleus of poorly differentiated PTC stage IV× 400, b High expression in the nucleus of moderately differentiated PTC stage III× 400, c low expression in the nucleus of well differentiated PTC stage IIx400, d low expression in the nucleus of well differentiated PTC stage Ix400 e negative expression in adjacent non-neoplastic thyroid follicles x400

Back to article page

Surgical and Experimental Pathology

ISSN: 2520-8454

Contact us